Recent Developments in the Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder (ADHD)

Professional Psychology: Research and Practice

Volumn 33, Issue 6, 2002, Pages 591-595

  Brown, Ronald T ^a,b,c,d   La Rosa, Angela ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Department of Health Professions ^*  (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036927023     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.33.6.591     Document Type: Review

References (38)

1. Abbott Pharmaceutical. (1996). Important drug warning [Letter]. North Chicago: Author.
2. American Academy of Pediatrics. (2000). Treatment guideline for diagnosis of ADHD. Pediatrics, 105, 1158-1170.
3. American Academy of Pediatrics. (2001). Clinical practice guideline: Treatment of the school-age child with attention-deficit/hyperactivity disorder. Pediatrics, 108, 1033-1044.
4. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
5. Atkins, M. S., Pelham, W. E., & Licht, M. H. (1989). The differential validity of teacher ratings of inattention/overactivity and aggression. Journal of Abnormal Child Psychology, 17, 423-435.
6. Barkley, R. A. (1998). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford Press.
7. Barkley, R. A. Q. (2001). Genetics of childhood disorders: XVII. ADHD. Part I. The executive functions and ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1064-1068.
8. Bennett, F. C., Brown, R. T., Crzver, J., & Andersen, D. (1999). Stimulant medication for the child with attention deficit hyperactivity disorder. Pediatric Clinics of North America, 46, 924-944.
9. Biederman, J., Farone, S. V., Keenan, K., Knee, D., & Tsuang, M. T. (1990). Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 526-533.
10. Brown, R. T., Dingle, A. D., & Dreelin, E. (1997). Neuropsychological effects of stimulant medication on children's learning and behavior. In C. R. Reynolds & E. Fletch-Janzen (Eds.), Handbook of clinical child neuropsychology (2nd ed., pp. 539-572). New York: Plenum.
11. Brown, R. T., Freeman, W. S., Perrin, J. M., Stein, M. T., Amler, R. W., Feldman, H., et al. (2001). Prevalence and assessment of attention-defict/hyperactivity disorder in primary care settings. Pediatrics, 107, E43.
12. Brown, R. T., & Sammons, M. T. (2002). Pediatric psychopharmacology: A review of new developments and recent research. Professional Psychology: Research and Practice, 33, 135-147.
13. Brown, R. T., & Sawyer, M. G. (1998). Medications for school age children: Effects on learning and behavior. New York: Guilford Press.
14. Conners, C. K. (1997). The Conners Rating Scales - Revised. North Tonowanda, NY: Multi-Health Systems.
15. DuPaul, G. J., Anastapolous, A. D., Kwasnik, D., Barkley, R. A., & McMurray, M. B. (1996). Methylphenidate effects on children with attention deficit hyperactivity disorder: Self-reports of symptoms, side effects and self-esteem. Journal of Attention Disorders, I, 3-15.
16. DuPaul, G. J., Barkley, R. A., & Connor, D. F. (1998). Stimulants. In R. A. Barkley (Ed.), Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment (pp. 510-551). New York: Guilford Press.
17. Ernst, M., et al. (1997). Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology, 17, 391-401.
18. Gadow, K. D. (1997). An overview of three decades of research in pediatric psychopharmacology. Journal of Child and Adolescent Psychopharmacology, 7, 219-236.
19. Hinshaw, S. P. (2000). Family processes and treatment outcomes in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. Journal of Abnormal Child Psychology, 28, 555-568.
20. Horrigan, J. P., & Barnhill, L. J. (1995). Guanfacine for treatment of attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 5, 215-223.
21. Hunt, R. D., Arnsten, A., & Asbell, M. D. (1995). An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder in boys. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 50-54.
22. Hunt, R. D., Capper, L., & O'Connell, P. (1990). Clonidine in child and adolescent psychiatry. Journal of Child and Adolescent Psychopharmacology, I, 87-102.
23. Klein, R. G., & Mannuzza, S. (1988). Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Archives of General Psychiatry, 45, 1131-1134.
24. Jacobvitz, D., Sroufe, A. L., Stewart, M., & Leffert, N. (1990). Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 677-688.
25. Jadad, A., Boyle, M., Cunningham, C., Kim, M., & Schachar, R. (1999). Treatment of ADHD (Evidence Rep./Tech. Assessment No. 00-E005/Pub. No. 00-E005). Rockville, MD: Agency for Healthcare Research and Quality.
26. Novartis. (2001). Information for patients taking Focalin or for their patients or caregivers. East Hanover, NJ: Novartis Pharmaceutical Corporation.
27. Pelham, W. E., Jr. (1999). The NIMH multimodal treatment study for attention deficit hyperactivity disorder: Just say yes to drugs alone? Canadian Journal of Psychiatry, 10, 981-990.
28. Pelham, W. E., Gnagy, E. M., Greiner, A. R., Hoza, B., Hinshaw, S. P., Swanson, J. M., et al. (2000). Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology, 28, 507-525.
29. Pelham W. E., Wheeler, T., & Chronis, A. (1998). Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. Journal of Clinical Child Psychology, 27, 190-205.
30. Peterson, B. S., & Cohen, D. J. (1998). The treatment of Tourette's syndrome: Multimodal, developmental intervention. Journal of Clinical Psychiatry, 59(Suppl. 1), 62-72.
31. Phelps, L., Brown, R. T., & Power, T. J. (2002). Pediatric psychopharmacology: Combining medical and psychosocial interventions, Washington, DC: American Psychological Association.
32. Safer, D. J., & Krager, J. M. (1988). A survey of medication treatment for hyperactive/inattentive students. Journal of the American Medical Association, 260, 2256-2258.
33. Swanson, J. M., Flockhart, D., & Udrea, D. (1995). Clonidine in the treatment of ADHD: Questions about safety and efficacy. Journal of Child and Adolescent Psychopharmacology, 5, 301-304.
34. Swanson, J., Gupta, S., Guinta, D., Flynn, D., Agler, D., Lerner, M., et al. (1999). Acute tolerance to methylphenidate in the treatment of ADHD in children. Clinical Pharmacological Therapy, 66, 295-305.
35. Werry, J. S., & Aman, M. G. (1999). Practitioner's guide to psychoactive drugs for children and adolescents (2nd ed.). New York: Plenum Press.
36. Zametkin, A. J., et al. 1990). Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New England Journal of Medicine, 323, 1361-1366.
37. Zeiner, P. (1995). Body growth and cardiovascular function after extended treatment (1.75 years) with methylphenidate in boys with attention-deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 5, 129-138.
38. Zito, J. M., et al. (2000). Trends in the prescribing of psychotropic medication to preschoolers. Journal of the American Medical Association, 283, 1025-1030.